Get the Stockscreener App
0.765
3.21%
0.0238
Virax Biolabs Group Ltd stock is traded at $0.765, with a volume of 17,641.
It is up +3.21% in the last 24 hours and down -24.63% over the past month.
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
See More
Previous Close:
$0.7412
Open:
$0.7599
24h Volume:
17,641
Relative Volume:
0.20
Market Cap:
$3.32M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.0403
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
-1.26%
1M Performance:
-24.63%
6M Performance:
-59.09%
1Y Performance:
-85.23%
1-Day Range:
$0.7509
$0.78
1-Week Range:
$0.74
$0.801
52-Week Range:
$0.7222
$7.63
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Name
Virax Biolabs Group Ltd
Sector
Industry
Phone
-
Address
-
Compare VRAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.765 | 3.40M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Initiated | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Stock (VRAX) Latest News
How to manage a losing position in Virax Biolabs Group LimitedWeekly Gains Summary & Community Verified Swing Trade Signals - Newser
Automated trading signals detected on Virax Biolabs Group LimitedJuly 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Significant Decrease in Short Interest - Defense World
How to interpret RSI for MetaVia Inc. stockEarnings Performance Report & Accurate Buy Signal Notifications - Newser
Will Virax Biolabs Group Limited stock recover after recent dropQuarterly Risk Review & Smart Money Movement Alerts - Newser
Real time pattern detection on Virax Biolabs Group Limited stockCPI Data & Risk Controlled Swing Trade Alerts - Newser
Volume spikes in Virax Biolabs Group Limited stock – what they meanPortfolio Return Summary & AI Driven Stock Reports - Newser
Is Virax Biolabs Group Limited stock entering bullish territory2025 Trade Ideas & Reliable Intraday Trade Plans - Newser
Is Virax Biolabs Group Limited stock reversal real or fakeJuly 2025 Sentiment & Daily Volume Surge Trade Alerts - Newser
Published on: 2025-08-16 07:16:15 - Newser
Smart tools for monitoring Virax Biolabs Group Limited’s price action2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
Can momentum traders help lift Virax Biolabs Group LimitedJuly 2025 News Drivers & Daily Technical Forecast Reports - Newser
Analyzing drawdowns of Virax Biolabs Group Limited with statistical tools2025 AllTime Highs & Accurate Entry/Exit Alerts - Newser
Virax Biolabs Group Limited Attempts Reversal From Key Support2025 Fundamental Recap & Long-Term Growth Plans - beatles.ru
Market reaction to Virax Biolabs Group Limited’s recent newsStop Loss & Short-Term High Return Strategies - Newser
Applying big data sentiment scoring on Virax Biolabs Group LimitedFree Trend Following Strategy With Stop Loss - Newser
Virax Biolabs Group Limited stock trend forecastPrice Spike Prediction for Active Traders - Newser
Using AI based signals to follow Virax Biolabs Group LimitedRapid Trade Forecast Based on Indicators - Newser
What makes Virax Biolabs Group Limited stock price move sharplyFree Secure Return Focused Investment Plan - Newser
Visualizing Virax Biolabs Group Limited stock with heatmapsFree Real Time Stock Movement Analysis - Newser
Does Virax Biolabs Group Limited stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
How does Virax Biolabs Group Limited generate profit in a changing economyCapitalize on emerging industry trends - Jammu Links News
What catalysts could drive Virax Biolabs Group Limited stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
Is it the right time to buy Virax Biolabs Group Limited stockBuild a diversified portfolio for steady growth - Jammu Links News
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director - TipRanks
Published on: 2025-07-30 13:38:22 - beatles.ru
How to build a custom watchlist for Virax Biolabs Group LimitedHigh Yield Signals with Entry Timing - Newser
Virax Biolabs Group Limited’s volatility index tracking explainedFree Risk Controlled Picks With Real Returns - Newser
Virax Biolabs appoints Iain Miller as independent director - Investing.com Australia
Former GE Healthcare Executive Joins Virax Board to Accelerate Diagnostic Platform Expansion - Stock Titan
Using economic indicators to assess Virax Biolabs Group Limited potentialFree Real Profit Trade Plan Suggestions - Newser
Is Virax Biolabs Group Limited stock overvalued or undervaluedFree Daily Trading Room Entry - jammulinksnews.com
What are the latest earnings results for Virax Biolabs Group LimitedBuild wealth with steady, reliable stocks - Jammu Links News
Why is Virax Biolabs Group Limited stock attracting strong analyst attentionGet real-time alerts on top stocks - Jammu Links News
Technical Analysis: TGB Banquets and Hotels Limited (532845)Consistent wealth multiplication - Autocar Professional
Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional
Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com
What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com
What analysts say about Virax Biolabs Group Limited stockExceptional market performance - Jammu Links News
AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser
ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com
What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional
Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com India
Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia
Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan
Virax Biolabs Group Ltd Stock (VRAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):